Cinnulin impresses in oxidative stress study

30 October 2006

Florida, USA-based Integrity Nutraceuticals International, a supplier of bulk nutritional ingredients, says that data from a new study indicate that its proprietary cinnamon extract, Cinnulin PF, may reduce the oxidative stress associated with metabolic syndrome. The results, which were presented at the annual meeting of the American College of Nutrition in Reno, Nevada, also indicated that treatment with Cinnulin PF allowed greater control of blood sugar levels.

The study, which was run as a placebo-controlled, double-blind assessment that enrolled 24 patients with impaired insulin function, examined the extract's antioxident properties, in terms of both ferric reducing ability of plasma (FRAP) and plasma sulfhydryl (thiol) levels, as well as its impact on glucose metabolism.

The results showed that those who received a 250mg dose of the compound twice daily for 12 weeks, achieved significant reductions in both FRAP and thiol levels, when compared with the placebo group. In addition, the study showed that the extract reduced levels of the oxidative stress biomarker malondialdehyde (MDA). Richard Anderson, of the US Department of Agriculture, said that the study demonstrates the potential benefits of the extract in protecting against harmful oxidative stress.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight